Related references
Note: Only part of the references are listed.Allergic Responses induced by the immunomodulatory effects of Nanomaterials upon Skin exposure
Yasuo Yoshioka et al.
FRONTIERS IN IMMUNOLOGY (2017)
Nucleic acid-sensing TLRs: trafficking and regulation
Olivia Majer et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys
Melissa A. Kachura et al.
JOURNAL OF IMMUNOLOGY (2016)
Species-dependent role of type I IFNs and IL-12 in the CTL response induced by humanized CpG complexed with β-glucan
Kouji Kobiyama et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2016)
Molecular mechanisms of regulation of Toll-like receptor signaling
Cynthia A. Leifer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?
Sharan Bobbala et al.
PHARMACEUTICAL RESEARCH (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Recent advances in the molecular design of synthetic vaccines
Lyn H. Jones
NATURE CHEMISTRY (2015)
Innovative Delivery of siRNA to Solid Tumors by Super Carbonate Apatite
Xin Wu et al.
PLOS ONE (2015)
Recent progress concerning CpG DNA and its use as a vaccine adjuvant
Hidekazu Shirota et al.
EXPERT REVIEW OF VACCINES (2014)
Combination of Liposomal CpG Oligodeoxynucleotide 2006 and Miltefosine Induces Strong Cell-Mediated Immunity during Experimental Visceral Leishmaniasis
Rahul Shivahare et al.
PLOS ONE (2014)
Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
Kouji Kobiyama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
CpG ODN Nanorings Induce IFNα from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity
Bilgi Gungor et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
Julia Scheiermann et al.
VACCINE (2014)
Particulate Adjuvant and Innate Immunity: Past Achievements, Present Findings, and Future Prospects
Etsushi Kuroda et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2013)
Immunization with Biodegradable Nanoparticles Efficiently Induces Cellular Immunity and Protects against Influenza Virus Infection
Torben Knuschke et al.
JOURNAL OF IMMUNOLOGY (2013)
Efficient Delivery of the Toll-like Receptor Agonists Polyinosinic:Polycytidylic Acid and CpG to Macrophages by Acetalated Dextran Microparticles
Kevin J. Peine et al.
MOLECULAR PHARMACEUTICS (2013)
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
Alexandre de Titta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Immunogenicity and safety of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in patients with chronic kidney disease
Robert S. Janssen et al.
VACCINE (2013)
TLR9 adjuvants enhance immunogenicity and protective efficacy of the SE36/AHG malaria vaccine in nonhuman primate models
Takahiro Tougan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity
Brian J. Laidlaw et al.
PLOS PATHOGENS (2013)
Signal 3 Cytokines as Modulators of Primary Immune Responses during Infections: The Interplay of Type I IFN and IL-12 in CD8 T Cell Responses
Selina Jessica Keppler et al.
PLOS ONE (2012)
Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
Benjamin P. Sablan et al.
VACCINE (2012)
Binding Mode of CpG Oligodeoxynucleotides to Nanoparticles Regulates Bifurcated Cytokine induction via Toll-like Receptor 9
Shanmugavel Chinnathambi et al.
SCIENTIFIC REPORTS (2012)
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity
Paul J. Tacken et al.
BLOOD (2011)
Regulation of effector and memory T-cell functions by type I interferon
Jonathan P. Huber et al.
IMMUNOLOGY (2011)
pH-sensitive carbonate apatite as an intracellular protein transporter
Seiichi Tada et al.
BIOMATERIALS (2010)
Designing CD8+T cell vaccines: it's not rocket science (yet)
Jonathan W. Yewdell
CURRENT OPINION IN IMMUNOLOGY (2010)
Carbonate apatite-facilitated intracellularly delivered siRNA for efficient knockdown of functional genes
Sharif Hossain et al.
JOURNAL OF CONTROLLED RELEASE (2010)
TLR9-Targeted Biodegradable Nanoparticles as Immunization Vectors Protect against West Nile Encephalitis
Stacey L. Demento et al.
JOURNAL OF IMMUNOLOGY (2010)
Bifurcation of Toll-Like Receptor 9 Signaling by Adaptor Protein 3
Miwa Sasai et al.
SCIENCE (2010)
The role of phagosomal pH on the size-dependent efficiency of cross-presentation by dendritic cells
Kenny K. Tran et al.
BIOMATERIALS (2009)
Vaccines: the Fourth Century
Stanley A. Plotkin
CLINICAL AND VACCINE IMMUNOLOGY (2009)
Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response
Stefan Fischer et al.
JOURNAL OF DRUG TARGETING (2009)
Nanoparticles target distinct dendritic cell populations according to their size
Vania Manolova et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
Carole Bourquin et al.
JOURNAL OF IMMUNOLOGY (2008)
A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles
Xue-Qing Zhang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Roberto Lande et al.
NATURE (2007)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
PH-sensing nano-crystals of carbonate apatite: Effects on intracellular delivery and release of DNA for efficient expression into mammalian cells
E. H. Chowdhury et al.
GENE (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Immunostimulatory properties of CpG-oligonucleotides are enhanced by the use of protamine nanoparticles
Miren Kerkmann et al.
OLIGONUCLEOTIDES (2006)
CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells
A Marschner et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction
K Honda et al.
NATURE (2005)
Cutting edge: Type IIFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation
JM Curtsinger et al.
JOURNAL OF IMMUNOLOGY (2005)
Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-α induction by CpG-A in plasmacytoid dendritic cells
M Kerkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration
M Heikenwalder et al.
NATURE MEDICINE (2004)
Vesicle size influences the trafficking, processing, and presentation of antigens in lipid vesicles
JM Brewer et al.
JOURNAL OF IMMUNOLOGY (2004)
Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis
J Rejman et al.
BIOCHEMICAL JOURNAL (2004)
CpG oligodeoxynucleotides protect normal and SIV-infected macaques from Leishmania infection
D Verthelyi et al.
JOURNAL OF IMMUNOLOGY (2003)
CpG oligodeoxynucleotides as vaccine adjuvants in primates
D Verthelyi et al.
JOURNAL OF IMMUNOLOGY (2002)
Sterically stabilized cationic liposomes improve the uptake and immunostimulatory activity of CpG oligonucleotides
I Gursel et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
